Execution risk in capacity ramp-up
Management acknowledged that stabilizing 10x capacity expansion is a 'marathon task' and may delay revenue inflection to FY27.
Azad Engineering · risk themes across the available quarters.
Bear-case history
Management acknowledged that stabilizing 10x capacity expansion is a 'marathon task' and may delay revenue inflection to FY27.
Contracts include termination clauses if performance fails; reliance on few large OEMs (Mitsubishi, Siemens, Safran) poses risk.
Despite natural hedge and 5% fluctuation cap, any sustained raw material price increase beyond cap could pressure margins.
Management declined to provide details on Safran MoU and GTRE engine program, citing defense sensitivity, creating uncertainty for investors.
Management acknowledged that commissioning and stabilizing new facilities involves significant upfront investment and time before revenue conversion, posing execution risk.
An analyst raised concerns about the Saudi Arabia JV with Baker Hughes; management confirmed timelines have shifted due to the current situation, though the opportunity remains.
Inventory buildup to support new plant ramp-ups has elevated working capital days; management expects normalization but any delay could pressure cash flows.
Growth relies on timely customer qualifications and audits; any delays in these processes could impact revenue conversion from the order book.